Cynthia Louise Flowers
CIK 1741455 · last filed 2026-01-13
Cynthia Louise Flowers is a corporate insider who has filed 24 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for LSTA, was dated Jan 13, 2026. Across all open-market trades the lifetime net is +$126.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $339.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$339.8K
4
24
$126.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LSTA | Director | 95,446 | $3.56 | $339.8K | $0 | 4 | 2026-01-13 |
| G1 Therapeutics, Inc. (GTHX) Delisted | Director | 15,889 | $7.15 | $113.6K | $26.2K | 9 | 2024-09-18 |
| LISATA THERAPEUTICS, INC. (CLBS) Delisted | Director | 145,847 | $6.40 | $932.8K | $0 | 5 | 2022-01-12 |
| Kadmon Holdings, Inc. (KDMN) Delisted | Director | 0 | $9.50 | $0 | $100.4K | 6 | 2021-11-09 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-13 | LSTA | Grant (A) | +30,456 | $0 | EDGAR |
| 2025-01-13 | LSTA | Grant (A) | +15,789 | $0 | EDGAR |
| 2024-09-18 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | −35,889 | $0 | EDGAR |
| 2024-06-14 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2024-01-11 | LSTA | Grant (A) | +19,480 | $0 | EDGAR |
| 2023-06-16 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2023-01-11 | LSTA | Grant (A) | +20,000 | $0 | EDGAR |
| 2022-06-24 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2022-01-12 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | +65,430 | $0 | EDGAR |
| 2021-11-09 | Kadmon Holdings, Inc. (KDMN) Delisted | Mixed | −31,000 | -$103.1K | EDGAR |